{"entities": {"annotations": [{"start": 73, "end": 77, "probability": 0.9794, "type": "Place", "normalized_text": "India"}], "hashtags": [{"start": 120, "end": 128, "tag": "COVAXIN"}], "mentions": [{"start": 0, "end": 14, "username": "BharatBiotech", "id": "2590932906"}, {"start": 15, "end": 25, "username": "ICMRDELHI", "id": "2695241174"}, {"start": 26, "end": 35, "username": "DBTIndia", "id": "1243467265"}, {"start": 36, "end": 45, "username": "icmr_niv", "id": "983637695443288064"}], "urls": [{"start": 131, "end": 154, "url": "https://t.co/DTNXlFanH3", "expanded_url": "https://www.dailywibes.com/2020/06/30/covaxin-all-we-know-about-indias-first-under-trial-coronavirus-vaccine/", "display_url": "dailywibes.com/2020/06/30/cov\u2026", "unwound_url": "https://www.dailywibes.com/2020/06/30/covaxin-all-we-know-about-indias-first-under-trial-coronavirus-vaccine/"}]}, "text": "@BharatBiotech @ICMRDELHI @DBTIndia @icmr_niv COVAXIN: All we know about India's first under trial coronavirus vaccine\n\n#COVAXIN \n\nhttps://t.co/DTNXlFanH3", "reply_settings": "everyone", "in_reply_to_user_id": "2590932906", "id": "1277883956826910720", "lang": "en", "possibly_sensitive": false, "referenced_tweets": [{"type": "replied_to", "id": "1277661065002676224"}], "created_at": "2020-06-30T08:37:31.000Z", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "conversation_id": "1277661065002676224", "author_id": "1270252428672278528", "source": "Twitter Web App"}